Leonard Schleifer (Photo by: Adam Jeffery/CNBC/NBCU Photo Bank via Getty Images)
Regeneron inks $1B+ deal for global rights to Sanofi-partnered PD-1 Libtayo
Sanofi CEO Paul Hudson made clear earlier this year that his mission to reshape the company would involve some pipeline pruning. For the right price …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.